Rapid Labs to develop and provide RNAssist’s molecular stabilisation reagents to the International Space Station

We are thrilled to announce that Rapid Labs and RNAssist Ltd are to provide two reagents to the International Space Station this year.

In December 2023, two of RNAssist’s molecular stabilisation reagents will be taken to the International Space Station (ISS) on SpaceX Dragon SpX-29 where they will be tested on microbial samples as part of a larger study in collaboration with NASA. This research is in partnership with Dr. Scott Tighe, Technical Director at the Advanced Genomics Lab at the University of Vermont, NASA-ISS uTitan Payload developer and Group leader Extreme Microbiome Project.

The International Space Station conducts a variety of scientific experiments every day across a number of different areas including climate forecasting, satellite technology and particle physics amongst many others. Inhabitants of the space station also participate in studies of how the human body can change in the absence of Earth’s gravity.

RNAssist reagents include vivoPHIX™, a novel RNA stabilisation reagent that preserves biomolecules and phosphoproteins, inactivates many viruses, bacteria and fungi and also offers the unique ability to dissociate single cells from tissue for downstream multi-omic analysis without the need for harsh enzymatic or mechanical processes. A recent publication by Fortmann et al (2023) highlights the many uses of vivoPHIX, which can be read online here.

Rapid Labs are the manufacturer and global distributor for RNAssist Ltd. For more information about vivoPHIX or to place an order please contact us at rnassist@rapidlabs.co.uk 

We wish Scott and all the team at Vermont and NASA-ISS all the best in this exciting research project!

We are thrilled to announce that Rapid Labs and RNAssist Ltd are to provide two reagents to the International Space Station this year.

In December 2023, two of RNAssist’s molecular stabilisation reagents will be taken to the International Space Station (ISS) on SpaceX Dragon SpX-29 where they will be tested on microbial samples as part of a larger study in collaboration with NASA. This research is in partnership with Dr. Scott Tighe, Technical Director at the Advanced Genomics Lab at the University of Vermont, NASA-ISS uTitan Payload developer and Group leader Extreme Microbiome Project.

The International Space Station conducts a variety of scientific experiments every day across a number of different areas including climate forecasting, satellite technology and particle physics amongst many others. Inhabitants of the space station also participate in studies of how the human body can change in the absence of Earth’s gravity.

RNAssist reagents include vivoPHIX™, a novel RNA stabilisation reagent that preserves biomolecules and phosphoproteins, inactivates many viruses, bacteria and fungi and also offers the unique ability to dissociate single cells from tissue for downstream multi-omic analysis without the need for harsh enzymatic or mechanical processes. A recent publication by Fortmann et al (2023) highlights the many uses of vivoPHIX, which can be read online here.

Rapid Labs are the manufacturer and global distributor for RNAssist Ltd. For more information about vivoPHIX or to place an order please contact us at rnassist@rapidlabs.co.uk 

We wish Scott and all the team at Vermont and NASA-ISS all the best in this exciting research project!